| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |